CALYM (original) (raw)
The CALYM Carnot Institute (Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field) is an academic research consortium focusing in lymphoma treatments and diagnosis spanning from new target identification to large international Phase III clinical trials and beyond. CALYM brings together 20 entities with complementary expertise in preclinical, translational and clinical lymphoma research: the Lymphoma Study Association (LYSA), the Lymphoma Academic Research Organisation (LYSARC), and 18 public preclinical research teams in lymphoma based at universities and hospitals across France. The consortium aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase and in the areas of therapeutic, diagnosis and imaging.
Property | Value |
---|---|
dbo:abstract | The CALYM Carnot Institute (Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field) is an academic research consortium focusing in lymphoma treatments and diagnosis spanning from new target identification to large international Phase III clinical trials and beyond. CALYM brings together 20 entities with complementary expertise in preclinical, translational and clinical lymphoma research: the Lymphoma Study Association (LYSA), the Lymphoma Academic Research Organisation (LYSARC), and 18 public preclinical research teams in lymphoma based at universities and hospitals across France. The consortium aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase and in the areas of therapeutic, diagnosis and imaging. The CALYM Carnot institute is managed by Bertrand Nadel. The steering committee of CALYM consortium is led by Guillaume Cartron. Carnot Institute is a label of excellence awarded by the French Ministry of Research to public-parapublic research institutes with a strong track record of partnering research. (en) |
dbo:wikiPageExternalLink | http://www.instituts-carnot.eu/en/carnot-institute/calym https://experts-recherche-lymphome.org/calym/ |
dbo:wikiPageID | 43015770 (xsd:integer) |
dbo:wikiPageLength | 5689 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID | 1121543288 (xsd:integer) |
dbo:wikiPageWikiLink | dbc:Cancer_research dbr:Rituximab dbr:Genetics dbr:Lymphoma dbr:Lyon dbr:Clinical_research dbr:Pharmacogenomics dbr:Diagnostic dbc:Cancer_organizations_based_in_France dbr:Therapeutic dbr:Alpha-interferon dbr:Preclinical_research |
dbp:wikiPageUsesTemplate | dbt:COI dbt:Citation_needed dbt:Multiple_issues dbt:Reflist dbt:Short_description dbt:Third-party |
dct:subject | dbc:Cancer_research dbc:Cancer_organizations_based_in_France |
gold:hypernym | dbr:Consortium |
rdf:type | yago:WikicatCancerOrganizations yago:Abstraction100002137 yago:Group100031264 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation dbo:PersonFunction yago:SocialGroup107950920 |
rdfs:comment | The CALYM Carnot Institute (Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field) is an academic research consortium focusing in lymphoma treatments and diagnosis spanning from new target identification to large international Phase III clinical trials and beyond. CALYM brings together 20 entities with complementary expertise in preclinical, translational and clinical lymphoma research: the Lymphoma Study Association (LYSA), the Lymphoma Academic Research Organisation (LYSARC), and 18 public preclinical research teams in lymphoma based at universities and hospitals across France. The consortium aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase and in the areas of therapeutic, diagnosis and imaging. (en) |
rdfs:label | CALYM (en) |
owl:sameAs | freebase:CALYM yago-res:CALYM wikidata:CALYM https://global.dbpedia.org/id/mrnJ |
prov:wasDerivedFrom | wikipedia-en:CALYM?oldid=1121543288&ns=0 |
foaf:isPrimaryTopicOf | wikipedia-en:CALYM |
is dbo:wikiPageRedirects of | dbr:Lymphoma_consortium |
is dbo:wikiPageWikiLink of | dbr:Gilles_Salles dbr:Lymphoma_consortium |
is foaf:primaryTopic of | wikipedia-en:CALYM |